CDKN1A and neoplasm: To investigate the efficiency of tumor-specific MRCP regulating endogenous gene expression in tumor cells for inhibiting the malignant phenotype, we constructed and evaluated MRCP to regulate cyclin-dependent kinase inhibitor 1A (CDKN1A) and Bax expression in tumor cells.